You are here

• Home
• Therapy Areas
• Gastrointestinal

• A Multicenter, Randomized, Open-label Phase IV Study Exploring Symptom Control Rate in Co-diagnosed NERD and Chronic Gastritis Patients Treated With 8 Weeks Esomeprazole Treatment Regimen and 2 Weeks Esomeprazole Treatment Regimen

Disease

gastroesophageal reflux disease

Drug Name

Nexium

Generic Name

Esomeprazole

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

IV

Start Date

Apr 12, 2010

Study Name

D9612L00127

Study Id

D9612L00127

ClinicalTrials.gov ID

NCT01119768

Recruiting Status

Closed

Report

May 28, 2012

• D9612L00127.pdf (633 KB)

Page tools

• Print
• Bookmark this page